H.C. Wainwright Reiterates Neutral Rating on Kyverna Therapeutics Inc (KYTX)
Tweet Send to a Friend
H.C. Wainwright analyst Mitchell S. Kapoor reiterated a Neutral rating and $8.00 price target on Kyverna Therapeutics Inc (NASDAQ: KYTX).The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
